Objective:
To evaluate the menstrual bleeding character, hemoglobin, hematocrit, and endometrial biopsy results before and after 1 year of treatment with Levonorgestrelreleasing intrauterine device in patients with abnormal uterine bleeding.
Material and Methods:
77 female patients in reproductive age, who have been treated with levonorgestrel-releasing intrauterine device for abnormal uterine bleeding, were enrolled in the study. Findings of the patients before and after the treatment were compared.
Results:
Significant changes in menstrual bleeding patterns were detected in 58 of 77 patients (75.32%) treated with Levonorgestrel-releasing intrauterine device for abnormal uterine bleeding. Increase in hemoglobin and hematocrit values were determined. 11 patients (14.28%) did not experience any change in vaginal bleeding complaints.
Conclusion:
Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding is a reliable and effective treatment.
Keywords: abnormal uterine bleeding, hemoglobin, levonorgestrel